20
Items sold in last 3 hours
amla parimala tab 200tab upto 20% off pavaman pharmaceuticals
₹600.00 inc. Tax
Highlights
amla parimala tab 200tab upto 20% off pavaman pharmaceuticals
buy more get more
5% off on 2 piece
10% off on 4 piece
15% off on 6 piece
20% off on 8 piece
183
People watching this product now!
Worldwide shipping offered
26 in stock
About Product
Description
Description
amla parimala tab 200tab upto 20% off pavaman pharmaceuticals
Amlaparimala Tablet: 100 tablets
Helps in the treatment of hyper acidity, Heart burn, reflex esophagitis, and vomiting, peptic ulcer and helps to balance of three doshas.
Ingredients: Sariva, Laghusuta shekara, Praval Panchamrit, Godanti Bhasma, Patoladi ghanakwatha, Patha.
Dosage: One or two tablet twice day or doctor advice.
Brand: Pavaman Pharmaceuticals
Additional information
Additional information
Weight | 300.0 g |
---|---|
Brand |
Reviews (0)
Reviews (0)
Rated 0 out of 5
0 reviews
Rated 5 out of 5
0
Rated 4 out of 5
0
Rated 3 out of 5
0
Rated 2 out of 5
0
Rated 1 out of 5
0
Be the first to review “amla parimala tab 200tab upto 20% off pavaman pharmaceuticals” Cancel reply
You must be logged in to post a review.
Best Before
Expires in between 6 Months to 2 Years from Today
our courier partner
Customer review
Rated 0 out of 5
0 reviews
Rated 5 out of 5
0
Rated 4 out of 5
0
Rated 3 out of 5
0
Rated 2 out of 5
0
Rated 1 out of 5
0
Reviews
Clear filtersThere are no reviews yet.
Be the first to review “amla parimala tab 200tab upto 20% off pavaman pharmaceuticals” Cancel reply
You must be logged in to post a review.
Reviews (0)
Reviews (0)
Rated 0 out of 5
0 reviews
Rated 5 out of 5
0
Rated 4 out of 5
0
Rated 3 out of 5
0
Rated 2 out of 5
0
Rated 1 out of 5
0
Reviews
Clear filtersThere are no reviews yet.
Be the first to review “amla parimala tab 200tab upto 20% off pavaman pharmaceuticals” Cancel reply
You must be logged in to post a review.
Related Products
alitox 60tab upto 15% off Sharangdhar, Pune best
Rated 0 out of 5
Save: 5%
Reviews
Clear filtersThere are no reviews yet.